Pneumococcal infections can be very serious ... vaccine if they have had a severe allergic reaction to any PCV vaccine or any vaccine containing diphtheria toxoid. (This includes the DTaP shot.) If ...

Background Widespread use of 7-valent pneumococcal conjugate vaccine (PCV7) in children has led to significant reduction in pneumococcal disease in children and adults. However, diseases caused by ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

Vaccine series completion for rotavirus, DTaP, PCV at 12 months was highest in January 2020 and remained lower in October 2023.

[8,9] Vaccines ... interval tetanus and diphtheria vaccination, the annual influenza vaccination and a singular pneumococcal vaccination, using the 23-valent PPV dose, while PCV is also licensed.

Phase 2 dose-finding study evaluating the safety, tolerability and immunogenicity of VAX-24, the Company’s 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive ...

Vaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting all endpoints. The Nasdaq-listed company saw its stock price, drop from ...